Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 16/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.39 |
| ▸ | PTPRC | P08575 | 3/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4136093 | 0.84 | KMT2A (0.38) | NPC1RAB9AKDM4EHTTMAOA | |
| SCHEMBL4121383 | 0.81 | ALDH1A1 (0.45) | PTPN1PTPN2PTPRCNPC1RAB9A | |
| SCHEMBL4120133 | 0.78 | PTPN1 (0.49) | PTPN1PTPN2PTPRC | |
| SCHEMBL4120616 | 0.78 | RAB9A (0.51) | NPC1RAB9AKDM4EHTT | |
| SCHEMBL4126845 | 0.76 | PTPN1 (0.44) | PTPN1PTPN2PTPRCRIPK1NPC1 | |
| SCHEMBL4127309 | 0.76 | PTPN1 (0.49) | PTPN1PTPN2PTPRC | |
| SCHEMBL13926050 | 0.75 | MCL1 (0.57) | PTPN1PTPN2PTPRCNPC1RAB9A | |
| SCHEMBL4118684 | 0.75 | PTPN1 (0.46) | PTPN1PTPN2PTPRC | |
| SCHEMBL4132062 | 0.74 | PTPN1 (0.47) | PTPN1PTPN2PTPRC | |
| SCHEMBL4125928 | 0.74 | PTPN1 (0.45) | PTPN1PTPN2PTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090048286-A1 | Inhibitors of Protein Tyrosine Phosphatase 1B | WYETH (US) | 2009-02-19 | — | — | US | disclosed |
| US-20050203081-A1 | Inhibitors of protein tyrosine phosphatase 1B | WYETH | 2005-09-15 | — | — | US | disclosed |
| WO-2005081960-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | WYETH (US) | 2005-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203081-A1 | Inhibitors of protein tyrosine phosphatase 1B | PTPRS, PTPRO, PTPRM | PTPN1 11/4885PTPN2 23/4885PTPRC 13/4885 |
| US-20090048286-A1 | Inhibitors of Protein Tyrosine Phosphatase 1B | PTPRS, PTPRO, PTPRM | PTPN1 11/4885PTPN2 23/4885PTPRC 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.